We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Design and evaluation of a ZP3 peptide vaccine in a homologous primate model.
- Authors
Paterson, M.; Wilson, M. R.; Jennings, Z. A.; van Duin, M.; Aitken, R. J.
- Abstract
The concept of a safe, immunocontraceptive vaccine using the zona pellucida glycoprotein 3 (ZP3) as an immunogen has been marred by the appearance of ovarian dysfunction in several species. However, careful selection of epitopes on mouse ZP3 have demonstrated that it is possible to segregate contraceptive bone marrow-derived (B)-cell epitopes from the cytotoxic thymus-derived (T)-cell epitopes thought to be responsible for inducing ovarian disease. B-cell epitopes on marmoset ZP3 (mstZP3) were identified by epitope mapping studies. Using a panel of polyclonal antibodies against recombinant mstZP3, an immunodominant epitope mstZP3301-320 was identified. A chimeric peptide was co-linearly synthesized incorporating this sequence with a promiscuous tetanus toxoid T-helper cell epitope. Using the common marmoset (Callithrix jacchus) as an animal model, we have compared the consequences of active immunization with homologous recombinant mstZP3 and mstZP3301-320 chimeric peptide vaccine. Long-term infertility was achieved using mstZP3 but at the expense of ovarian function. In contrast, no disruption to ovarian function was observed following mstZP3301-320 immunization. Antibodies to this peptide immunolocalized to the zona pellucida of both marmoset and human ovarian sections and inhibited human sperm-zona binding by ~60% in vitro. However, in-vivo studies indicated that targeting a single ZP3 epitope was insufficient to reliably and consistently achieve a contraceptive effect.
- Subjects
ZONA pellucida domain proteins; EPITOPES; PEPTIDES; ZONA pellucida; IMMUNIZATION
- Publication
Molecular Human Reproduction, 1999, Vol 5, Issue 4, p342
- ISSN
1360-9947
- Publication type
Article
- DOI
10.1093/molehr/5.4.342